Association of Matrix Metalloproteinase-1 -1607 1G/2G and C-Reactive Protein -717 C/T Gene Polymorphisms in Iranian Patients with Chronic Periodontitis: A Clinical Trial
To Cite:
Vahabi
S, Nazemisalman
B, Kalantari
M, Hosseinpour
S. Association of Matrix Metalloproteinase-1 -1607 1G/2G and C-Reactive Protein -717 C/T Gene Polymorphisms in Iranian Patients with Chronic Periodontitis: A Clinical Trial,
Iran Red Crescent Med J.
2019
; 21(1):e84396.
doi: 10.5812/ircmj.84396.
3.
Armitage GC. Periodontal diagnoses and classification of periodontal diseases. Periodontol 2000. 2004;34:9-21. [PubMed: 14717852].
4.
Wang J, Qi J, Zhao H, He S, Zhang Y, Wei S, et al. Metagenomic sequencing reveals microbiota and its functional potential associated with periodontal disease. Sci Rep. 2013;3:1843. doi: 10.1038/srep01843. [PubMed: 23673380]. [PubMed Central: PMC3654486].
5.
Bergstrom J. Cigarette smoking as risk factor in chronic periodontal disease. Community Dent Oral Epidemiol. 1989;17(5):245-7. [PubMed: 2791514].
6.
Genco RJ, Ho AW, Grossi SG, Dunford RG, Tedesco LA. Relationship of stress, distress and inadequate coping behaviors to periodontal disease. J Periodontol. 1999;70(7):711-23. doi: 10.1902/jop.1999.70.1.100. [PubMed: 10440631].
7.
Chen X, Huang J, Zhong L, Ding C. Quantitative assessment of the associations between interleukin-8 polymorphisms and periodontitis susceptibility. J Periodontol. 2015;86(2):292-300. doi: 10.1902/jop.2014.140450. [PubMed: 25299389].
8.
Ding C, Zhao L, Sun Y, Li L, Xu Y. Interleukin-1 receptor antagonist polymorphism (rs2234663) and periodontitis susceptibility: A meta-analysis. Arch Oral Biol. 2012;57(6):585-93. doi: 10.1016/j.archoralbio.2012.01.016. [PubMed: 22370044].
9.
Mao S, Zhang J, Zhao M, Zhang Y. Association of transforming growth factor-beta1 polymorphisms with the risk of diabetes mellitus. Int J Clin Exp Med. 2015;8(11):21886-92. [PubMed: 26885158]. [PubMed Central: PMC4724004].
10.
Sorsa T, Tjaderhane L, Konttinen YT, Lauhio A, Salo T, Lee HM, et al. Matrix metalloproteinases: Contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med. 2006;38(5):306-21. doi: 10.1080/07853890600800103. [PubMed: 16938801].
11.
Page RC, Offenbacher S, Schroeder HE, Seymour GJ, Kornman KS. Advances in the pathogenesis of periodontitis: Summary of developments, clinical implications and future directions. Periodontol 2000. 1997;14:216-48. [PubMed: 9567973].
12.
Garlet GP, Martins W Jr, Ferreira BR, Milanezi CM, Silva JS. Patterns of chemokines and chemokine receptors expression in different forms of human periodontal disease. J Periodontal Res. 2003;38(2):210-7. [PubMed: 12608917].
13.
Okada H, Murakami S. Cytokine expression in periodontal health and disease. Crit Rev Oral Biol Med. 1998;9(3):248-66. [PubMed: 9715365].
14.
Taubman MA, Valverde P, Han X, Kawai T. Immune response: The key to bone resorption in periodontal disease. J Periodontol. 2005;76 Suppl 11S:2033-41. doi: 10.1902/jop.2005.76.11-S.2033. [PubMed: 29539039].
15.
Romero JR, Vasan RS, Beiser AS, Polak JF, Benjamin EJ, Wolf PA, et al. Association of carotid artery atherosclerosis with circulating biomarkers of extracellular matrix remodeling: The Framingham offspring study. J Stroke Cerebrovasc Dis. 2008;17(6):412-7. doi: 10.1016/j.jstrokecerebrovasdis.2008.06.002. [PubMed: 18984437]. [PubMed Central: PMC2613480].
16.
Hulejova H, Baresova V, Klezl Z, Polanska M, Adam M, Senolt L. Increased level of cytokines and matrix metalloproteinases in osteoarthritic subchondral bone. Cytokine. 2007;38(3):151-6. doi: 10.1016/j.cyto.2007.06.001. [PubMed: 17689092].
17.
Adley BP, Gleason KJ, Yang XJ, Stack MS. Expression of membrane type 1 matrix metalloproteinase (MMP-14) in epithelial ovarian cancer: high level expression in clear cell carcinoma. Gynecol Oncol. 2009;112(2):319-24. doi: 10.1016/j.ygyno.2008.09.025. [PubMed: 18976802]. [PubMed Central: PMC2663392].
18.
Verstappen J, Von den Hoff JW. Tissue inhibitors of metalloproteinases (TIMPs): Their biological functions and involvement in oral disease. J Dent Res. 2006;85(12):1074-84. doi: 10.1177/154405910608501202. [PubMed: 17122157].
19.
Hannas AR, Pereira JC, Granjeiro JM, Tjaderhane L. The role of matrix metalloproteinases in the oral environment. Acta Odontol Scand. 2007;65(1):1-13. doi: 10.1080/00016350600963640. [PubMed: 17354089].
20.
Ejeil AL, Igondjo-Tchen S, Ghomrasseni S, Pellat B, Godeau G, Gogly B. Expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in healthy and diseased human gingiva. J Periodontol. 2003;74(2):188-95. doi: 10.1902/jop.2003.74.2.188. [PubMed: 12666707].
21.
Kubota T, Nomura T, Takahashi T, Hara K. Expression of mRNA for matrix metalloproteinases and tissue inhibitors of metalloproteinases in periodontitis-affected human gingival tissue. Arch Oral Biol. 1996;41(3):253-62. [PubMed: 8735011].
22.
Ingman T, Sorsa T, Michaelis J, Konttinen YT. Immunohistochemical study of neutrophil- and fibroblast-type collagenases and stromelysin-1 in adult periodontitis. Scand J Dent Res. 1994;102(6):342-9. [PubMed: 7871357].
23.
Cao Z, Li C, Jin L, Corbet EF. Association of matrix metalloproteinase-1 promoter polymorphism with generalized aggressive periodontitis in a Chinese population. J Periodontal Res. 2005;40(6):427-31. doi: 10.1111/j.1600-0765.2005.00806.x. [PubMed: 16302919].
24.
Ravanti L, Kahari VM. Matrix metalloproteinases in wound repair (review). Int J Mol Med. 2000;6(4):391-407. [PubMed: 10998429].
26.
Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, et al. Matrix metalloproteinases: A review. Crit Rev Oral Biol Med. 1993;4(2):197-250. doi: 10.1177/10454411930040020401. [PubMed: 8435466].
27.
Holla LI, Jurajda M, Fassmann A, Dvorakova N, Znojil V, Vacha J. Genetic variations in the matrix metalloproteinase-1 promoter and risk of susceptibility and/or severity of chronic periodontitis in the Czech population. J Clin Periodontol. 2004;31(8):685-90. doi: 10.1111/j.1600-051X.2004.00547.x. [PubMed: 15257748].
28.
de Souza AP, Trevilatto PC, Scarel-Caminaga RM, Brito RB, Line SR. MMP-1 promoter polymorphism: Association with chronic periodontitis severity in a Brazilian population. J Clin Periodontol. 2003;30(2):154-8. [PubMed: 12622858].
29.
Ramamoorthy RD, Nallasamy V, Reddy R, Esther N, Maruthappan Y. A review of C-reactive protein: A diagnostic indicator in periodontal medicine. J Pharm Bioallied Sci. 2012;4(Suppl 2):S422-6. doi: 10.4103/0975-7406.100318. [PubMed: 23066303]. [PubMed Central: PMC3467901].
30.
Husain TM, Kim DH. C-reactive protein and erythrocyte sedimentation rate in orthopaedics. Univ Pa Orthop J. 2002;15:13-6.
31.
Dave S, Batista EL Jr, Van Dyke TE. Cardiovascular disease and periodontal diseases: Commonality and causation. Compend Contin Educ Dent. 2004;25(7 Suppl 1):26-37. [PubMed: 15645884].
33.
Loos BG. Systemic markers of inflammation in periodontitis. J Periodontol. 2005;76(11 Suppl):2106-15. doi: 10.1902/jop.2005.76.11-S.2106. [PubMed: 16277583].
34.
Teeuw WJ, Slot DE, Susanto H, Gerdes VE, Abbas F, D'Aiuto F, et al. Treatment of periodontitis improves the atherosclerotic profile: A systematic review and meta-analysis. J Clin Periodontol. 2014;41(1):70-9. doi: 10.1111/jcpe.12171. [PubMed: 24111886].
35.
Paraskevas S, Huizinga JD, Loos BG. A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. J Clin Periodontol. 2008;35(4):277-90. doi: 10.1111/j.1600-051X.2007.01173.x. [PubMed: 18294231].
36.
Auerkari E, Suhartono A, Djamal N, Verisqa F, Suryandari D, Kusdhany L, et al. CRP and IL-1B gene polymorphisms and CRP in blood in periodontal disease. Open Dent J. 2013;7:88-93. doi: 10.2174/1874210601307010088. [PubMed: 24009648]. [PubMed Central: PMC3758952].
37.
Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215. [PubMed: 3344216]. [PubMed Central: PMC334765].
38.
Gospodarowicz D, Neufeld G, Schweigerer L. Molecular and biological characterization of fibroblast growth factor, an angiogenic factor which also controls the proliferation and differentiation of mesoderm and neuroectoderm derived cells. Cell Differ. 1986;19(1):1-17. [PubMed: 2425984].
39.
Bimstein E, Karimbux N, Needleman HL, Van Dyke TE. Periodontal and gingival health and diseases: Children, adolescents and young adults. CRC Press; 2001.
40.
Li W, Zhu Y, Singh P, Ajmera DH, Song J, Ji P. Association of common variants in MMPs with periodontitis risk. Dis Markers. 2016;2016:1545974. doi: 10.1155/2016/1545974. [PubMed: 27194818]. [PubMed Central: PMC4853955].
41.
Kasamatsu A, Uzawa K, Shimada K, Shiiba M, Otsuka Y, Seki N, et al. Elevation of galectin-9 as an inflammatory response in the periodontal ligament cells exposed to Porphylomonas gingivalis lipopolysaccharide in vitro and in vivo. Int J Biochem Cell Biol. 2005;37(2):397-408. doi: 10.1016/j.biocel.2004.07.014. [PubMed: 15474984].
42.
Dowsett SA, Archila L, Foroud T, Koller D, Eckert GJ, Kowolik MJ. The effect of shared genetic and environmental factors on periodontal disease parameters in untreated adult siblings in Guatemala. J Periodontol. 2002;73(10):1160-8. doi: 10.1902/jop.2002.73.10.1160. [PubMed: 12416774].
43.
Pizzo G, Guiglia R, Lo Russo L, Campisi G. Dentistry and internal medicine: From the focal infection theory to the periodontal medicine concept. Eur J Intern Med. 2010;21(6):496-502. doi: 10.1016/j.ejim.2010.07.011. [PubMed: 21111933].
44.
D'Aiuto F, Casas JP, Shah T, Humphries SE, Hingorani AD, Tonetti MS. C-reactive protein (+1444C>T) polymorphism influences CRP response following a moderate inflammatory stimulus. Atherosclerosis. 2005;179(2):413-7. doi: 10.1016/j.atherosclerosis.2004.10.036. [PubMed: 15777561].
Readers' Comments